Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Tekijä Erskine, Courtney L., Henle, Andrea M., Knutson, Keith L.
Julkaistu 2012

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells

Tekijä Henle, Andrea M., Erskine, Courtney L., Benson, Linda M., Clynes, Raphael, Knutson, Keith L.
Julkaistu 2012

Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis

Tekijä Pennington, Kelly, Sasieta, Humberto C, Ramos, Guiherme P, Erskine, Courtney L, Van Keulen, Virginia P, Peikert, Tobias, Escalante, Patricio
Julkaisussa Clin Med Insights Case Rep (2017)

Plasma immune analytes in patients with epithelial ovarian cancer

Tekijä Block, Matthew S., Maurer, Matthew J., Goergen, Krista, Kalli, Kimberly R., Erskine, Courtney L., Behrens, Marshall D., Oberg, Ann L., Knutson, Keith L.
Julkaisussa Cytokine (2015)

Tumor infiltrating PD-1(+) dendritic cells mediate immune suppression in ovarian cancer

Tekijä Krempski, James, Karyampudi, Lavakumar, Behrens, Marshall D., Erskine, Courtney L., Hartmann, Lynn, Dong, Haidong, Goode, Ellen L., Kalli, Kimberly R., Knutson, Keith L.
Julkaistu 2011

Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer

Tekijä Carlson, Aaron M., Maurer, Matthew J., Goergen, Krista M., Kalli, Kimberly R., Erskine, Courtney L., Behrens, Marshall D., Knutson, Keith L., Block, Matthew S.
Julkaistu 2013

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

Tekijä Behrens, Marshall D., Wagner, Wolfgang M., Krco, Christopher J., Erskine, Courtney L., Kalli, Kimberly R., Krempski, James, Gad, Ekram A., Disis, Mary L., Knutson, Keith L.
Julkaistu 2008

MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells

Tekijä Erskine, Courtney L., Krco, Christopher J., Hedin, Karen E., Borson, Nancy D., Kalli, Kimberly R., Behrens, Marshall D., Heman-Ackah, Sabrina M., von Hofe, Eric, Wettstein, Peter J., Mohamadzadeh, Mansour, Knutson, Keith L.
Julkaistu 2011

Improved survival of HER2+ breast cancer patients treated with trastuzumab and chemotherapy is associated with host antibody immunity against the HER2 intracellular domain

Tekijä Knutson, Keith L., Clynes, Raphael, Shreeder, Barath, Yeramian, Patrick, Kemp, Kathleen P., Ballman, Karla, Tenner, Kathleen S., Erskine, Courtney L., Norton, Nadine, Northfelt, Donald, Tan, Winston, Calfa, Carmen, Pegram, Mark, Mittendorf, Elizabeth A., Perez, Edith A.
Julkaisussa Cancer Res (2016)

Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification

Tekijä Escalante, Patricio, Peikert, Tobias, Van Keulen, Virginia P., Erskine, Courtney L., Bornhorst, Cathy L., Andrist, Boleyn R., McCoy, Kevin, Pease, Larry R., Abraham, Roshini S., Knutson, Keith L., Kita, Hirohito, Schrum, Adam G., Limper, Andrew H.
Julkaisussa Am J Respir Crit Care Med (2015)

An HLA-DR–Degenerate Epitope Pool Detects Insulin-like Growth Factor Binding Protein 2–Specific Immunity in Patients with Cancer

Tekijä Kalli, Kimberly R., Krco, Christopher J., Hartmann, Lynn C., Goodman, Karin, Maurer, Matthew J., Yu, Chao, Johnson, Elliot M., Erskine, Courtney L., Disis, Mary L., Wettstein, Peter J., Fikes, John D., Beebe, Melanie, Ishioka, Glenn, Knutson, Keith L.
Julkaistu 2008

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

Tekijä Norton, Nadine, Fox, Nicholas, McCarl, Christie-Ann, Tenner, Kathleen S., Ballman, Karla, Erskine, Courtney L., Necela, Brian M., Northfelt, Donald, Tan, Winston W., Calfa, Carmen, Pegram, Mark, Colon-Otero, Gerardo, Perez, Edith A., Clynes, Raphael, Knutson, Keith L.
Julkaisussa Breast Cancer Res (2018)

A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu(88-102)

Tekijä Karyampudi, Lavakumar, Formicola, Courtney, Erskine, Courtney L., Maurer, Matthew J., Ingle, James N., Krco, Christopher J., Wettstein, Peter J., Kalli, Kimberly R., Fikes, John D., Beebe, Melanie, Hartmann, Lynn C., Disis, Mary L., Ferrone, Soldano, Ishioka, Glenn, Knutson, Keith L.
Julkaistu 2010

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

Tekijä Kalli, Kimberly R., Block, Matthew S., Kasi, Pashtoon M., Erskine, Courtney L., Hobday, Timothy J., Dietz, Allan B., Padley, Douglas J., Gustafson, Michael P., Visscher, Dan W., Puglisi-Knutson, Danell J., Shreeder, Barath, Mangskau, Toni K., Wilson, Glynn, Knutson, Keith L.
Julkaisussa Clin Cancer Res (2018)

Rapid generation of sustainable HER2-specific T cell immunity in HER2 breast cancer patients using a degenerate HLA class II epitope vaccine

Tekijä Knutson, Keith L., Block, Matthew S., Norton, Nadine, Erskine, Courtney L., Hobday, Timothy J., Dietz, Allan B., Padley, Douglas J., Gustafson, Michael P., Puglisi-Knutson, Danell J., Mangskau, Toni K., Chumsri, Saranya, Dueck, Amylou C., Karyampudi, Lavakumar, Wilson, Glynn, Degnim, Amy
Julkaisussa Clin Cancer Res (2019)

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen

Tekijä Karyampudi, Lavakumar, Krco, Christopher J., Kalli, Kimberly R., Erskine, Courtney L., Hartmann, Lynn C., Goodman, Karin, Ingle, James N., Maurer, Matthew J., Nassar, Aziza, Yu, Chao, Disis, Mary L., Wettstein, Peter J., Fikes, John D., Beebe, Melanie, Ishioka, Glenn, Knutson, Keith L.
Julkaistu 2009

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

Tekijä Zamarin, Dmitriy, Walderich, Sven, Holland, Aliya, Zhou, Qin, Iasonos, Alexia E, Torrisi, Jean M, Merghoub, Taha, Chesebrough, Lewis F, Mcdonnell, Autumn S, Gallagher, Jacqueline M, Li, Yanyun, Hollmann, Travis J, Grisham, Rachel N, Erskine, Courtney L, Block, Mathew S, Knutson, Keith L, O’Cearbhaill, Roisin E, Aghajanian, Carol, Konner, Jason A
Julkaisussa J Immunother Cancer (2020)

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Tekijä Block, Matthew S., Dietz, Allan B., Gustafson, Michael P., Kalli, Kimberly R., Erskine, Courtney L., Youssef, Bahaaeldin, Vijay, Geraldine V., Allred, Jacob B., Pavelko, Kevin D., Strausbauch, Michael A., Lin, Yi, Grudem, Megan E., Jatoi, Aminah, Klampe, Carolyn M., Wahner-Hendrickson, Andrea E., Weroha, S. John, Glaser, Gretchen E., Kumar, Amanika, Langstraat, Carrie L., Solseth, Mary L., Deeds, Michael C., Knutson, Keith L., Cannon, Martin J.
Julkaisussa Nat Commun (2020)

Neoantigenic potential of complex chromosomal rearrangements in mesothelioma

Tekijä Mansfield, Aaron S., Peikert, Tobias, Smadbeck, James B., Udell, Julia B. M., Garcia-Rivera, Enrique, Elsbernd, Laura, Erskine, Courtney L., Van Keulen, Virginia P., Kosari, Farhad, Murphy, Stephen J., Ren, Hongzheng, Serla, Vishnu V., Klein, Janet L. Schaefer, Karagouga, Giannoula, Harris, Faye R., Sosa, Carlos, Johnson, Sarah H., Nevala, Wendy, Markovic, Svetomir N., Bungum, Aaron O., Edell, Eric S., Dong, Haidong, Cheville, John C., Aubry, Marie Christine, Jen, Jin, Vasmatzis, George
Julkaisussa J Thorac Oncol (2018)